Jubilant Pharmova received a significant win as the Income Tax Department deleted a ₹22.10 crore tax demand for AY 2020-21. This removes a contingent liability, but related litigation is ongoing.

Jubilant Pharmova Gains Relief in Tax Litigation

Jubilant Pharmova has seen a ₹22.10 crore tax demand for the Assessment Year 2020-21 fully deleted following a rectification order from the Income Tax Department.

Reader Takeaway: Tax demand removed, but further litigation pending.

What just happened

The Income Tax Department has issued a rectification order, completely removing a tax demand of ₹22.10 crore against Jubilant Pharmova for Assessment Year 2020-21. This follows a rectification application filed by the company that highlighted errors in the original assessment order.

Why this matters

This development provides immediate relief by eliminating a significant contingent tax liability from the company's books. It strengthens the company's financial position by removing a potential outflow of funds.

The backstory

Jubilant Pharmova had contested the tax demand for AY 2020-21, believing there were mistakes in the assessment. The company proactively applied for rectification, leading to this favorable outcome.

What changes now

The direct financial impact is the removal of the ₹22.10 crore liability. The company's balance sheet will reflect this positive change, reducing uncertainty.

Risks to watch

Despite this win, the company has an ongoing appeal before the Income Tax Appellate Tribunal (ITAT) for the same assessment year, but on different grounds. This means the tax litigation for AY 2020-21 is not entirely concluded.

Peer comparison

(No specific peer data available in the filing)

Context metrics (time-bound)

Tax demand deleted for Assessment Year 2020-21: ₹22.10 crore.

What to track next

Investors should monitor the outcome of the separate appeal pending before the ITAT concerning the Assessment Year 2020-21.